Evidence map›Paper›PMID 30995771›Full record

ArticleNutrients2019

A Comprehensive Assessment of Apigenin as an Antiproliferative, Proapoptotic, Antiangiogenic and Immunomodulatory Phytocompound.

Alexandra Ghițu, Anja Schwiebs, Heinfried H Radeke, Stefana Avram, Istvan Zupko, Andrea Bor, Ioana Zinuca Pavel, Cristina Adriana Dehelean, Camelia Oprean, Florina Bojin and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Article
  3. Formulation and Biological Evaluation ofAntioxidants (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Cutaneous Polymeric-Micelles-Based Hydrogel ContainingPharmaceuticals (Basel, Switzerland) · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Alexandra GhițuDepartment of Pharmacognosy, "Victor Babeş" University of Medicine and Pharmacy, 2, Eftimie Murgu Square, 300041 Timişoara, Romania. ghitu.alexandra@gmail.com.
Anja SchwiebsPharmazentrum Frankfurt/ZAFES, Institute of General Pharmacology and Toxicology, Clinic of the Goethe University, D-60590 Frankfurt/Main, Germany. schwiebs@med.uni-frankfurt.de.
Heinfried H RadekePharmazentrum Frankfurt/ZAFES, Institute of General Pharmacology and Toxicology, Clinic of the Goethe University, D-60590 Frankfurt/Main, Germany. radeke@em.uni-frankfurt.de.
Stefana AvramDepartment of Pharmacognosy, "Victor Babeş" University of Medicine and Pharmacy, 2, Eftimie Murgu Square, 300041 Timişoara, Romania. stefana.avram@umft.ro.
Istvan ZupkoDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary. zupko@pharm.u-szeged.hu.ORCID 0000-0003-3243-5300
Andrea BorDepartment of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary. andrea.bor@pharm.u-szeged.hu.
Ioana Zinuca PavelDepartment of Pharmacognosy, "Victor Babeş" University of Medicine and Pharmacy, 2, Eftimie Murgu Square, 300041 Timişoara, Romania. ioanaz.pavel@umft.ro.
Cristina Adriana DeheleanDepartment of Toxicology, "Victor Babeş" University of Medicine and Pharmacy, 2, Eftimie Murgu Square, 300041 Timişoara, Romania. cadehelean@umft.ro.
Camelia OpreanDepartment of Drug Analysis, Chemistry of the Environment and Food, "Victor Babeş" University of Medicine and Pharmacy, 2, Eftimie Murgu Square, 300041 Timişoara, Romania. camelia.oprean@umft.ro.
Florina BojinOncoGen Centre, "Pius Brînzeu" Emergency County Hospital, 156, Liviu Rebreanu Boulevard, 300736 Timişoara, Romania. florinabojin@umft.ro.
Claudia FarcasDepartment of Pharmaceutical Physics, "Victor Babeş" University of Medicine and Pharmacy, 2, Eftimie Murgu Square, 300041 Timişoara, Romania. farcas.claudia@umft.ro.
Codruta SoicaDepartment of Pharmaceutical Chemistry, "Victor Babeş" University of Medicine and Pharmacy, 2, Eftimie Murgu Square, 300041 Timişoara, Romania. codrutasoica@umft.ro.
Oana DuicuDepartment of Functional Sciences-Pathophysiology, "Victor Babeş" University of Medicine and Pharmacy, 2, Eftimie Murgu Square, 300041 Timişoara, Romania. oanaduicu@umft.ro.
Corina DanciuDepartment of Pharmacognosy, "Victor Babeş" University of Medicine and Pharmacy, 2, Eftimie Murgu Square, 300041 Timişoara, Romania. corina.danciu@umft.ro.
Victor Babeș University of Medicine and Pharmacy Timișoara · ROGoethe University Frankfurt · DESpitalul Clinic Judeţean de Urgenţă "Pius Brînzeu" Timişoara · ROUniversity of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apigenin (4',5,7-trihydroxyflavone) (Api) is an important component of the human diet, being distributed in a wide number of fruits, vegetables and herbs with the most important sources being represented by chamomile, celery, celeriac and parsley. This study was designed for a comprehensive evaluation of Api as an antiproliferative, proapoptotic, antiangiogenic and immunomodulatory phytocompound. In the set experimental conditions, Api presents antiproliferative activity against the A375 human melanoma cell line, a G2/M arrest of the cell cycle and cytotoxic events as revealed by the lactate dehydrogenase release. Caspase 3 activity was inversely proportional to the Api tested doses, namely 30 μM and 60 μM. Phenomena of early apoptosis, late apoptosis and necrosis following incubation with Api were detected by Annexin V-PI double staining. The flavone interfered with the mitochondrial respiration by modulating both glycolytic and mitochondrial pathways for ATP production. The metabolic activity of human dendritic cells (DCs) under LPS-activation was clearly attenuated by stimulation with high concentrations of Api. Il-6 and IL-10 secretion was almost completely blocked while TNF alpha secretion was reduced by about 60%. Api elicited antiangiogenic properties in a dose-dependent manner. Both concentrations of Api influenced tumour cell growth and migration, inducing a limited tumour area inside the application ring, associated with a low number of capillaries.

Indexed as

DietMelanomaAdenosine TriphosphateAngiogenesis InhibitorsAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicApigeninApoptosisCaspase 3Cell Cycle CheckpointsCell Line, TumorCell MovementCell ProliferationCytokinesDendritic CellsHumansAdenosine TriphosphateAngiogenesis InhibitorsAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicApigeninCaspase 3CytokinesImmunologic FactorsLipopolysaccharidesL-Lactate DehydrogenasePlant ExtractsA375 human melanoma cell lineangiogenesisapigeninapoptosismitochondrial bioenergetics and glycolysisproliferation

Identifiers

PMID30995771
PMCPMC6521017
OpenAlexW2940298401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.